Authorities are focusing on compliance, consumer protection and the accuracy of product claims across all sales channels. / Credit: onapalmtree via Shutterstock
Thailand’s Food and Drug Administration (Thai FDA) is strengthening oversight of dietary supplement advertising as part of a wider crackdown on exaggerated health claims, targeting misleading marketing across retail and online channels.
The move reflects growing regulatory pressure on the global dietary supplements market, where inaccurate product claims and health misinformation remain a persistent issue.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Thai FDA is coordinating with multiple agencies to improve enforcement and consumer protection, with a focus on advertising compliance and product transparency.
Integrated enforcement approach
The Thai FDA has expanded collaboration with partner organisations to monitor and act against misleading health product advertising, including dietary supplements. The agency’s integrated model aims to improve detection and speed up enforcement actions across media platforms.
False or exaggerated claims are prohibited under Thai regulations, particularly those suggesting that supplements can treat or prevent disease.
Authorities are prioritising cases where advertising misleads consumers about product benefits, ingredients or outcomes. This includes claims that overstate weight loss effects, beauty benefits or medical properties—areas that have historically generated high levels of non-compliance.
Previous enforcement efforts have shown that a significant share of problematic advertising relates to supplements, often promoted through broadcast and digital channels.
High prevalence of misleading supplement claims
Recent studies and enforcement data highlight the scale of the issue in the dietary supplements sector. Research on Thai e-commerce platforms found that more than 80% of supplement listings contained unapproved or misleading claims about health benefits.
Common issues include:
Overstated weight loss or body transformation effects
Claims implying disease treatment or prevention
Use of unauthorised wording or endorsements
Thai regulations define health claims broadly, covering any statement or implication linking a product to health outcomes. Even indirect wording such as “supports” or “helps” may require regulatory approval and scientific evidence.
For retailers and distributors, this creates compliance risks across product listings, packaging and marketing content, particularly in cross-border e-commerce.
Implications for retailers and global supply chains
The crackdown has direct implications for retailers operating in Thailand and across Southeast Asia’s health supplements market. Businesses must ensure that all product claims are accurate, substantiated and aligned with local regulations.
Key compliance considerations include:
Verifying that marketing claims match approved product labelling
Avoiding medical or therapeutic language in supplement advertising
Monitoring third-party sellers and online marketplaces
Thailand’s regulatory approach is preventive, meaning non-compliant claims can block products from entering the market rather than triggering action after sale.
The tightening of rules also reflects a broader global trend. Regulators in multiple markets are increasing scrutiny of food supplement advertising, driven by rising online sales and the spread of health-related misinformation.
For international retailers, the Thai FDA’s actions signal the need for stronger governance over product content and marketing practices, particularly in fast-growing digital retail channels.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
